Dld Asset Management, LP Insmed Inc Put Options Transaction History

Dld Asset Management, LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2019 Aug 14, 2019	SELL	$23.0 - $32.19 $1.25 Million - $1.75 Million	-54,500 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$13.91 - $31.15 $8.44 Million - $18.9 Million	-607,000 Reduced 91.76%	54,500 $1.58 Million
Q4 2018 Feb 13, 2019	BUY	$11.6 - $18.7 $990,640 - $1.6 Million	85,400 Added 14.82%	661,500 $8.67 Million
Q3 2018 Nov 13, 2018	SELL	$18.95 - $28.08 $130,755 - $193,752	-6,900 Reduced 1.18%	576,100 $11.6 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $9.46 Million - $14.1 Million	473,000 Added 430.0%	583,000 $13.8 Million
Q1 2018 May 14, 2018	BUY	$21.69 - $32.99 $2.39 Million - $3.63 Million	110,000 New	110,000 $2.48 Million
Q4 2017 Feb 12, 2018	SELL	$26.43 - $31.78 $9.96 Million - $12 Million	-376,700 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $4.37 Million - $11.8 Million	376,700	376,700 $11.8 Million

484

187M

2.15M

3.22M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.